BRD4 and ovarian carcinoma: Tumor type had the largest effect on BRD4 expression (measured in FPKM), with ovarian cancer having the largest positive effect (regression coefficient: 26.1, 95% confidence interval [CI]: 22.5–29.7; Figure 2E).